These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10822722)

  • 1. [Apolipoprotein C-II and C-III anomalies in normolipemic and hyperlipemic patients with chronic kidney failure].
    Tornero F; García-Garzón A; Rincón B; Prieto S; Usón J; Lozano L
    Nefrologia; 2000; 20(1):47-53. PubMed ID: 10822722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of Apo B48, and relative Apo CII deficiency and Apo CIII enrichment in uremic very-low density lipoproteins.
    Atger V; Beyne P; Frommherz K; Roullet JB; Drüeke T
    Ann Biol Clin (Paris); 1989; 47(8):497-501. PubMed ID: 2690681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein abnormalities in chronic haemodialysis patients.
    Parsy D; Dracon M; Cachera C; Parra HJ; Vanhoutte G; Tacquet A; Fruchart JC
    Nephrol Dial Transplant; 1988; 3(1):51-6. PubMed ID: 3132640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dyslipidemia in patients with chronic renal failure and in renal transplant patients.
    Shah B; Nair S; Sirsat RA; Ashavaid TF; Nair KG
    J Postgrad Med; 1994; 40(2):57-60. PubMed ID: 8737552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable effects of soy protein on plasma lipids in hyperlipidemic and normolipidemic hemodialysis patients.
    Chen ST; Ferng SH; Yang CS; Peng SJ; Lee HR; Chen JR
    Am J Kidney Dis; 2005 Dec; 46(6):1099-106. PubMed ID: 16310576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anomalies of lipoprotein metabolism in chronic renal insufficiency].
    Lacour B; Massy ZA; Jungers P; Drueke T
    Nephrologie; 1993; 14(2):75-90. PubMed ID: 8327031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
    Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid and apolipoproteins (ApoAI, ApoB, Apo CIII, ApoE) disturbance in hemodialysis (HD) and renal transplant (Tx) patients.
    Janicki K; Solski J; Janicka L; Kimak E; Bednarek-Skublewska A; Stettner S; Molas G
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):459-66. PubMed ID: 16146031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid and lipoprotein metabolism in chronic kidney disease.
    Kaysen GA
    J Ren Nutr; 2009 Jan; 19(1):73-7. PubMed ID: 19121776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum apolipoprotein C-II and apolipoprotein E levels and their lipoprotein distributions in chronic hemodialysis].
    Yukawa S; Nishikawa O; Miyai T; Maeda T; Mori K; Hibino A; Takahashi T; Maeda A; Nomoto H; Nishikawa N
    Nihon Jinzo Gakkai Shi; 1984 Oct; 26(10):1361-8. PubMed ID: 6527435
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure.
    Sentí M; Romero R; Pedro-Botet J; Pelegrí A; Nogués X; Rubiés-Prat J
    Kidney Int; 1992 May; 41(5):1394-9. PubMed ID: 1614054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
    Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
    Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into apolipoprotein C metabolism from transgenic and gene-targeted mice.
    Jong MC; Havekes LM
    Int J Tissue React; 2000; 22(2-3):59-66. PubMed ID: 10937355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].
    Kes P; Reiner Z; Brunetta B
    Lijec Vjesn; 2002; 124(11-12):372-7. PubMed ID: 12679979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation, dyslipidemia and vascular risk factors in hemodialysis patients.
    Wanner C; Zimmermann J; Quaschning T; Galle J
    Kidney Int Suppl; 1997 Nov; 62():S53-5. PubMed ID: 9350681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful kidney transplantation does not reverse the coagulopathy in patients with chronic renal failure on either hemo or peritoneal dialysis.
    Ballow A; Gader AM; Huraib S; Mitwalli A; Al-Suleimani F; Al-Wakeel J
    Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):177-85. PubMed ID: 17496391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between apolipoprotein C-III concentrations and high-density lipoprotein subclass distribution.
    Tian L; Wu J; Fu M; Xu Y; Jia L
    Metabolism; 2009 May; 58(5):668-74. PubMed ID: 19375590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein abnormalities in chronic renal failure and dialysis patients.
    Monzani G; Bergesio F; Ciuti R; Rosati A; Frizzi V; Serruto A; Vitali D; Benucci A; Tosi PL; Bandini S; Salvadori M
    Blood Purif; 1996; 14(3):262-72. PubMed ID: 8738541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.